About ABOzymes
ABOzymes is a Healthcare company based in Vancouver (Canada) founded in 2020. Blood transfusion services are provided by ABOzymes in healthcare settings. Its focus areas include Services for Healthcare Providers and Blood Banks.
Company details
ABOzymes was established in 2020 and is based in Vancouver, Canada. Operations center on blood transfusion services within the healthcare sector. Matching and delivery of blood components are handled to support medical procedures. The company maintains a domain at abozymes.com for its activities. Focus remains on standard protocols for transfusion safety and efficiency across regional facilities.
- Headquarters Vancouver, Canada
- SectorsHealthcare
- Website abozymes.com
- Social LinkedIn X
- InvestorsMitacs
& 2 more
Funding Insights of ABOzymes
- Total Rounds 2
- Investors Count 3
All 2 funding rounds of ABOzymes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | Seed | – | – | – | |
| Feb 2021 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in ABOzymes
ABOzymes has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Mitacs, Genome British Columbia and Canadian Glycomics Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Funds genomics research in health, forestry, fisheries, and education sectors. | 2010 | genomebc.ca | Vancouver, Canada | |
Research and innovation in glycomics are advanced by GlycoNet. | 2015 | canadianglycomics.ca | Edmonton, Canada | |
A foundation focused on economic development | 1999 | mitacs.ca | Montreal, Canada |
Investor details for ABOzymes
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ABOzymes
3 dated milestones of ABOzymes across 2 years, from founding to its latest funding, stage changes and deals.
- Founded ABOzymes is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ABOzymes
ABOzymes was founded in 2020 and raised its 1st funding round 1 year after it was founded.
ABOzymes is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
ABOzymes was established in 2020 and is based in Vancouver, Canada. Operations center on blood transfusion services within the healthcare sector. Matching and delivery of blood components are handled to support medical procedures. The company maintains a domain at abozymes.com for its activities. Focus remains on standard protocols for transfusion safety and efficiency across regional facilities.
ABOzymes has 3 investors. Key investors include Mitacs, Genome British Columbia, and Canadian Glycomics Network.